Shandong Rike Chemical Co.,LTD. (300214.SZ)
CNY 5.39
(4.05%)
CNY 5.39
(4.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -15.68 Million | 227.69 Million | 106.96 Million | 463.34 Million | 136.23 Million | 55.61 Million |
| Net Income | 84.33 Million | 196.39 Million | 190.16 Million | 207.03 Million | 177.91 Million | 102.76 Million |
| Depreciation & Amortization | 74.82 Million | 75.16 Million | 74.79 Million | 72.4 Million | 63.38 Million | 51.17 Million |
| Deferred income taxes | 2.3 Million | -38.51 Thousand | -19.18 Million | 1.22 Million | -1.77 Million | 254.23 Thousand |
| Stock-based compensation | -2.08 Million | 2.62 Million | - | - | - | - |
| Change in working capital | -166.31 Million | -39.82 Million | -163.77 Million | 174.7 Million | -117.69 Million | -55.82 Million |
| Other non-cash items | -3.26 Million | -4.04 Million | 5.77 Million | 9.19 Million | 12.64 Million | -42.49 Million |
| Investing Cash Flow | -448.63 Million | -216.24 Million | -498.7 Million | -327.52 Million | -158.84 Million | -37 Million |
| Investments in PPE | -719.66 Million | -211.82 Million | -171.79 Million | -142.77 Million | -161.61 Million | -99.83 Million |
| Acquisitions | 1.41 Million | 447.7 Thousand | 1.26 Million | -76.91 Million | 2.58 Million | 52.48 Million |
| Investment purchases | -6 Million | -2.95 Billion | -1.68 Billion | -110 Million | - | - |
| Sales/Maturities of investments | 16.86 Million | 12.57 Million | 6.82 Million | 109.99 Million | - | 10.34 Million |
| Other Investing Activities | 258.89 Million | 2.93 Billion | 1.35 Billion | -107.83 Million | 191.09 Thousand | 62.82 Million |
| Financing Cash Flow | 430.3 Million | 4.69 Million | 270.7 Million | -115.2 Million | -24.88 Million | -20.76 Million |
| Debt repayment | -465.32 Million | -33.66 Million | -25.56 Million | -101.7 Million | -151.77 Million | -38.42 Million |
| Dividends payments | -28 Million | -35.33 Million | -35.69 Million | -25.19 Million | -21.22 Million | -65.36 Million |
| Common Stock Repurchased | -2.58 Million | - | - | - | -33.63 Million | -6.31 Million |
| Common Stock Issuance | - | - | - | - | 33.63 Million | - |
| Other Financing Activities | -2.58 Million | 73.91 Million | 332.53 Million | 12.74 Million | 151.87 Million | 83.01 Million |
| Accounts receivables | -146.36 Million | 96.36 Million | -79.65 Million | 146.52 Million | -137.19 Million | -31.05 Million |
| Accounts payables | -29.21 Million | -209.19 Million | 30.4 Million | -10.96 Million | 107.8 Million | 913.1 Thousand |
| Inventory | 6.96 Million | 73.03 Million | -95.33 Million | 37.92 Million | -86.52 Million | -25.93 Million |
| Other working capital | -3.46 Million | -38.51 Thousand | -19.18 Million | 1.22 Million | -1.77 Million | -29.89 Million |
| Cash at beginning of period | 114.54 Million | 77.8 Million | 204.52 Million | 189.18 Million | 234.94 Million | 237.08 Million |
| Cash at end of period | 85.56 Million | 114.54 Million | 77.8 Million | 204.52 Million | 189.18 Million | 234.94 Million |
| Capital Expenditure | -719.66 Million | -211.82 Million | -171.79 Million | -142.77 Million | -161.61 Million | -99.83 Million |
| Effect of forex changes on cash | 5.02 Million | 20.59 Million | -5.69 Million | -5.28 Million | 1.73 Million | 17.93 Thousand |
| Net cash flow / Change in cash | -28.98 Million | 36.74 Million | -126.72 Million | 15.34 Million | -45.75 Million | -2.14 Million |
| Free Cash Flow | -735.35 Million | 15.86 Million | -64.83 Million | 320.57 Million | -25.38 Million | -44.21 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -10.01 Million | -33.6 Million | -8.71 Million | 2.28 Million | 84.33 Million | 23.95 Million |
| Depreciation & Amortization | - | 21.25 Million | 21.25 Million | 74.82 Million | 74.82 Million | -34.71 Million |
| Deferred income taxes | - | - | - | - | 2.3 Million | - |
| Stock-based compensation | - | - | - | -2.08 Million | -2.08 Million | - |
| Change in working capital | - | - | - | -142.86 Million | -166.31 Million | -3.27 Million |
| Other non-cash items | 47.19 Million | 99.96 Million | -112.8 Million | 126.21 Million | -3.26 Million | -78.82 Million |
| Investing Cash Flow | -95.1 Million | -172.38 Million | -182.78 Million | -239.27 Million | -448.63 Million | 22.48 Million |
| Investments in PPE | -84.6 Million | -177.6 Million | -228.2 Million | -327.88 Million | -719.66 Million | -257.84 Million |
| Acquisitions | 415.77 Thousand | 219.98 Thousand | - | 1.31 Million | 1.41 Million | -41.46 Thousand |
| Investment purchases | -149.75 Million | - | - | -857.6 Million | -6 Million | 765.55 Million |
| Sales/Maturities of investments | 1.96 Million | - | 37.3 Thousand | 3.04 Million | 16.86 Million | 6.53 Million |
| Other Investing Activities | -12.45 Million | 5 Million | 45.37 Million | 84.38 Million | 258.89 Million | -491.71 Million |
| Financing Cash Flow | 134.36 Million | 185.87 Million | 298.18 Million | 191.44 Million | 430.3 Million | 93.98 Million |
| Debt repayment | -160.85 Million | -226.01 Million | -298.66 Million | -196.23 Million | -465.32 Million | -94.98 Million |
| Dividends payments | -27.26 Million | -10.2 Million | -3.87 Million | -28 Million | -28 Million | -1 Million |
| Common Stock Repurchased | - | - | - | -2.58 Million | -2.58 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 773 Thousand | -29.93 Million | 3.4 Million | -2.58 Million | -2.58 Million | 189.97 Million |
| Accounts receivables | - | - | - | -146.36 Million | -146.36 Million | 33.48 Million |
| Accounts payables | - | - | - | - | -29.21 Million | - |
| Inventory | - | - | - | 6.96 Million | 6.96 Million | -44.57 Million |
| Other working capital | - | - | - | -3.46 Million | -3.46 Million | 7.81 Million |
| Cash at beginning of period | 143.06 Million | 83.15 Million | 87.31 Million | 72.63 Million | 114.54 Million | 55.47 Million |
| Cash at end of period | 218.68 Million | 143.06 Million | 83.15 Million | 85.56 Million | 85.56 Million | 72.63 Million |
| Capital Expenditure | -84.6 Million | -177.6 Million | -228.2 Million | -327.88 Million | -719.66 Million | -257.84 Million |
| Effect of forex changes on cash | 627.56 Thousand | 1.91 Million | 1.96 Million | 440.23 Thousand | 5.02 Million | -60.18 Thousand |
| Net cash flow / Change in cash | 75.62 Million | 59.9 Million | -4.15 Million | 12.92 Million | -28.98 Million | 17.16 Million |
| Free Cash Flow | -47.42 Million | -132.5 Million | -349.72 Million | -267.42 Million | -735.35 Million | -350.7 Million |
ZEAL
4366
FSKRS
BUD
AARTIDRUGS
IRRA